Reelvision Manufactures Prescription Packaging
Reelvision Print Ltd has been awarded the contract to produce the printed cartons for a multi-language range of a cancer medicines.
The drugs will be used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC). These drugs are used by patients who have not been treated before with a medicine of the ALK inhibitor class or who have been treated before with the ALK-inhibitor.
The Reelvision in-line one-pass print & die-cut with automatic waste removal process ensures no product admixture can occur. This underlines why Reelvision is the most appropriate manufacturer for this form of large range critical drug packaging.
